Biotechnology Stocks II Performance Guide: Cullinan Oncology, Inc. (CGEM)
CGEM has no dividends.
Table and Chart of CGEM Performance
See what a $1,000 investment in CGEM is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| CGEM Returns | |
|---|---|
| Start Date | Feb-26-2021 |
| Start Price | $40.42 |
| End Date | May-16-2024 |
| End Price | $23.81 |
| # Prices | 40 |
| Min Date | Nov-30-2023 |
| Min Price | $8.19 |
| Max Date | Mar-31-2021 |
| Max Price | $41.67 |
| Total Return | -41.09% |
| Annualized Return | -14.68% |
| Current Value of $1,000 Purchase | $589 |
| Number Returns | 780 |
| Average Return | -11.98% |
| Number Profitable Returns | 208 |
| Percent Profitable Returns | 26.67% |
| Number Unprofitable Returns | 572 |
| Percent Unprofitable Returns | 73.33% |
| Profitable to Unprofitable Returns Ratio | 0.36 |
| CGEM Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,025,392,000 |
| Beta | -0.004 | Price to Sales | 26.88 |
| Earnings per Share | $-3.6900 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.785 |
| PRICE DATA | |
| 52 Week High | $30.19 |
| 52 Week Low | $7.64 |
| Analyst Target Price | $33.14 |
| 50-Day Moving Average | $19.8 |
| 200-Day Moving Average | $13.26 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -29.5% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
CGEM Compare Returns with S&P 500
CGEM Trendline Chart
CGEM Moving Average Chart
CGEM Stock Return Map - See Patterns of Gains and Losses
CGEM Stock Returns/Purchase Dates